[1]
2021. Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis. Clinics. 76, (Nov. 2021), e1876. DOI:https://doi.org/10.6061/clinics/2021/e1876.